Chinese General Practice ›› 2022, Vol. 25 ›› Issue (02): 189-196.DOI: 10.12114/j.issn.1007-9572.2021.01.503
Special Issue: 呼吸疾病文章合集; 老年人群健康最新文章合集; 营养最新文章合集; 老年问题最新文章合集
• Article·Chronic Obstructive Pulmonary Disease • Previous Articles Next Articles
Correlation of Malnutrition,25-hydroxy Vitamin D and Interleukin-1β with Chronic Obstructive Pulmonary Disease in Elderly Inpatients
1.Medical School,Kunming University of Science and Technology,Kunming 650500,China
2.Department of Geriatrics,the First People's Hospital of Yunnan Province,Yunnan Branch of National Clinical Research Center for Geriatric Diseases,Dong Birong Expert Workstation,Kunming 650032,China
*Corresponding author:LI Yan,Professor,Chief physician,Doctoral supervisor,E-mail:liyanken@126.com
Received:
2021-08-06
Revised:
2021-11-15
Published:
2022-01-15
Online:
2021-12-29
通讯作者:
李燕
基金资助:
CLC Number:
DAI Jingrong, LI Jie, HE Xu, LI Yang, LI Yan.
Correlation of Malnutrition,25-hydroxy Vitamin D and Interleukin-1β with Chronic Obstructive Pulmonary Disease in Elderly Inpatients [J]. Chinese General Practice, 2022, 25(02): 189-196.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.01.503
项目 | 非COPD组(n=216) | COPD组(n=89) | χ2(t)值 | P值 | 项目 | 非COPD组(n=216) | COPD组(n=89) | χ2(t)值 | P值 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
年龄〔n(%)〕 | 15.757 | 0.001 | 焦虑/抑郁状态〔n(%)〕 | 147(68.1) | 58(65.2) | 0.238 | 0.625 | ||||
60~74岁 | 89(41.2) | 19(21.3) | 焦虑状态〔n(%)〕 | 22(10.2) | 17(19.1) | 4.493 | 0.034 | ||||
75~84岁 | 67(31.0) | 29(32.6) | 抑郁状态〔n(%)〕 | 115(53.2) | 62(69.7) | 6.979 | 0.008 | ||||
≥85岁 | 60(27.8) | 41(46.1) | 日常生活能力〔n(%)〕 | 6.843 | 0.077 | ||||||
性别〔n(%)〕 | 10.339 | 0.001 | 良好 | 95(44.0) | 31(34.8) | ||||||
男 | 120(55.6) | 67(75.3) | 轻度障碍 | 64(29.6) | 32(36.0) | ||||||
女 | 96(44.4) | 22(24.7) | 中度障碍 | 27(12.5) | 6(6.7) | ||||||
身高(![]() | 160.7±8.2 | 161.8±8.5 | -1.058a | 0.291 | 重度障碍、完全残疾 | 30(13.9) | 20(22.5) | ||||
体质量(![]() | 60.4±11.6 | 59.6±10.1 | 0.550a | 0.583 | 失能〔n(%)〕 | 106(49.1) | 59(66.3) | 7.525 | 0.006 | ||
体质指数(![]() | 23.3±3.6 | 23.0±5.7 | 0.528a | 0.598 | 睡眠状况〔n(%)〕 | 6.947 | 0.031 | ||||
文化程度〔n(%)〕 | 0.340 | 0.952 | 良好 | 111(51.4) | 31(34.8) | ||||||
文盲 | 7(3.2) | 2(2.2) | 潜在失眠 | 63(29.2) | 35(39.4) | ||||||
小学 | 67(31.0) | 27(30.3) | 失眠 | 42(19.4) | 23(25.8) | ||||||
中学 | 106(49.1) | 46(51.7) | 跌倒风险〔n(%)〕 | 1.568 | 0.457 | ||||||
大学及以上 | 36(16.7) | 14(15.8) | 低度 | 138(63.8) | 62(69.7) | ||||||
视力下降〔n(%)〕 | 153(70.8) | 64(71.9) | 0.036 | 0.850 | 中度 | 39(18.1) | 11(12.3) | ||||
听力下降〔n(%)〕 | 132(61.1) | 58(65.2) | 0.442 | 0.506 | 高度 | 39(18.1) | 16(18.0) | ||||
饮食习惯〔n(%)〕 | 0.010 | 0.918 | 平衡功能及步态〔n(%)〕 | 0.753 | 0.686 | ||||||
清淡饮食为主 | 181(83.8) | 75(84.3) | 平衡功能良好 | 110(50.9) | 46(51.7) | ||||||
咸腻饮食为主 | 35(16.2) | 14(15.7) | 平衡功能障碍 | 60(27.8) | 21(23.6) | ||||||
睡眠时间(![]() | 6.8±1.9 | 7.2±1.7 | -1.875a | 0.062 | 有跌倒风险 | 46(21.3) | 22(24.7) | ||||
当前吸烟〔n(%)〕 | 46(21.3) | 38(42.7) | 14.456 | <0.001 | 慢性疼痛〔n(%)〕 | 71(32.9) | 33(37.1) | 0.497 | 0.481 | ||
当前饮酒〔n(%)〕 | 38(17.6) | 24(27.0) | 3.420 | 0.064 | 便秘〔n(%)〕 | 62(28.7) | 24(27.0) | 0.094 | 0.759 | ||
营养状况〔n(%)〕 | 31.360 | <0.001 | 衰弱程度〔n(%)〕 | 6.308 | 0.043 | ||||||
营养良好 | 118(54.6) | 27(30.3) | 无衰弱 | 119(55.1) | 36(40.4) | ||||||
潜在营养不良 | 82(38.0) | 35(39.4) | 衰弱前期 | 53(24.5) | 33(37.1) | ||||||
营养不良 | 16(7.4) | 27(30.3) | 衰弱 | 44(20.4) | 20(22.5) | ||||||
认知功能〔n(%)〕 | 10.541 | 0.014 | 慢性病种数(![]() | 6.4±3.2 | 7.1±3.5 | -1.633a | 0.104 | ||||
正常 | 100(46.3) | 36(40.4) | 多重用药〔n(%)〕 | 126(58.3) | 63(70.8) | 4.147 | 0.042 | ||||
轻度障碍 | 79(36.6) | 23(25.8) | 用药种数(![]() | 5.5±3.1 | 6.5±3.1 | -2.418a | 0.016 | ||||
中度障碍 | 27(12.5) | 22(24.7) | |||||||||
重度障碍 | 10(4.6) | 8(9.1) |
Table 1 Comparison of general information and comprehensive geriatric assessment results between the two groups
项目 | 非COPD组(n=216) | COPD组(n=89) | χ2(t)值 | P值 | 项目 | 非COPD组(n=216) | COPD组(n=89) | χ2(t)值 | P值 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
年龄〔n(%)〕 | 15.757 | 0.001 | 焦虑/抑郁状态〔n(%)〕 | 147(68.1) | 58(65.2) | 0.238 | 0.625 | ||||
60~74岁 | 89(41.2) | 19(21.3) | 焦虑状态〔n(%)〕 | 22(10.2) | 17(19.1) | 4.493 | 0.034 | ||||
75~84岁 | 67(31.0) | 29(32.6) | 抑郁状态〔n(%)〕 | 115(53.2) | 62(69.7) | 6.979 | 0.008 | ||||
≥85岁 | 60(27.8) | 41(46.1) | 日常生活能力〔n(%)〕 | 6.843 | 0.077 | ||||||
性别〔n(%)〕 | 10.339 | 0.001 | 良好 | 95(44.0) | 31(34.8) | ||||||
男 | 120(55.6) | 67(75.3) | 轻度障碍 | 64(29.6) | 32(36.0) | ||||||
女 | 96(44.4) | 22(24.7) | 中度障碍 | 27(12.5) | 6(6.7) | ||||||
身高(![]() | 160.7±8.2 | 161.8±8.5 | -1.058a | 0.291 | 重度障碍、完全残疾 | 30(13.9) | 20(22.5) | ||||
体质量(![]() | 60.4±11.6 | 59.6±10.1 | 0.550a | 0.583 | 失能〔n(%)〕 | 106(49.1) | 59(66.3) | 7.525 | 0.006 | ||
体质指数(![]() | 23.3±3.6 | 23.0±5.7 | 0.528a | 0.598 | 睡眠状况〔n(%)〕 | 6.947 | 0.031 | ||||
文化程度〔n(%)〕 | 0.340 | 0.952 | 良好 | 111(51.4) | 31(34.8) | ||||||
文盲 | 7(3.2) | 2(2.2) | 潜在失眠 | 63(29.2) | 35(39.4) | ||||||
小学 | 67(31.0) | 27(30.3) | 失眠 | 42(19.4) | 23(25.8) | ||||||
中学 | 106(49.1) | 46(51.7) | 跌倒风险〔n(%)〕 | 1.568 | 0.457 | ||||||
大学及以上 | 36(16.7) | 14(15.8) | 低度 | 138(63.8) | 62(69.7) | ||||||
视力下降〔n(%)〕 | 153(70.8) | 64(71.9) | 0.036 | 0.850 | 中度 | 39(18.1) | 11(12.3) | ||||
听力下降〔n(%)〕 | 132(61.1) | 58(65.2) | 0.442 | 0.506 | 高度 | 39(18.1) | 16(18.0) | ||||
饮食习惯〔n(%)〕 | 0.010 | 0.918 | 平衡功能及步态〔n(%)〕 | 0.753 | 0.686 | ||||||
清淡饮食为主 | 181(83.8) | 75(84.3) | 平衡功能良好 | 110(50.9) | 46(51.7) | ||||||
咸腻饮食为主 | 35(16.2) | 14(15.7) | 平衡功能障碍 | 60(27.8) | 21(23.6) | ||||||
睡眠时间(![]() | 6.8±1.9 | 7.2±1.7 | -1.875a | 0.062 | 有跌倒风险 | 46(21.3) | 22(24.7) | ||||
当前吸烟〔n(%)〕 | 46(21.3) | 38(42.7) | 14.456 | <0.001 | 慢性疼痛〔n(%)〕 | 71(32.9) | 33(37.1) | 0.497 | 0.481 | ||
当前饮酒〔n(%)〕 | 38(17.6) | 24(27.0) | 3.420 | 0.064 | 便秘〔n(%)〕 | 62(28.7) | 24(27.0) | 0.094 | 0.759 | ||
营养状况〔n(%)〕 | 31.360 | <0.001 | 衰弱程度〔n(%)〕 | 6.308 | 0.043 | ||||||
营养良好 | 118(54.6) | 27(30.3) | 无衰弱 | 119(55.1) | 36(40.4) | ||||||
潜在营养不良 | 82(38.0) | 35(39.4) | 衰弱前期 | 53(24.5) | 33(37.1) | ||||||
营养不良 | 16(7.4) | 27(30.3) | 衰弱 | 44(20.4) | 20(22.5) | ||||||
认知功能〔n(%)〕 | 10.541 | 0.014 | 慢性病种数(![]() | 6.4±3.2 | 7.1±3.5 | -1.633a | 0.104 | ||||
正常 | 100(46.3) | 36(40.4) | 多重用药〔n(%)〕 | 126(58.3) | 63(70.8) | 4.147 | 0.042 | ||||
轻度障碍 | 79(36.6) | 23(25.8) | 用药种数(![]() | 5.5±3.1 | 6.5±3.1 | -2.418a | 0.016 | ||||
中度障碍 | 27(12.5) | 22(24.7) | |||||||||
重度障碍 | 10(4.6) | 8(9.1) |
项目 | 非COPD组(n=216) | COPD组(n=89) | t(Z)值 | P值 | 项目 | 非COPD组(n=216) | COPD组(n=89) | t(Z)值 | P值 |
---|---|---|---|---|---|---|---|---|---|
白细胞计数(![]() | 6.7±2.9 | 6.7±1.9 | 0.027 | 0.979 | T3(![]() | 1.11±0.43 | 1.07±0.30 | 1.011 | 0.313 |
血红蛋白(![]() | 132±23 | 138±28 | -1.649 | 0.101 | T4(![]() | 79.01±21.30 | 74.10±11.71 | 2.575 | 0.011 |
血小板计数(![]() | 208.3±77.4 | 185.4±70.3 | 2.410 | 0.017 | 铁蛋白(![]() | 326.30±285.71 | 298.38±400.38 | 0.686 | 0.493 |
NEUT〔M(P25,P75),×109/L〕 | 3.87(2.83,4.90) | 4.26(3.48,5.30) | -1.861a | 0.063 | 维生素B12〔M(P25,P75),pmol/L〕 | 352.50(230.25,499.14) | 398.00(254.50,580.00) | -1.478a | 0.139 |
C反应蛋白〔M(P25,P75),mg/L〕 | 3.47(0.77,21.03) | 7.34(2.51,21.82) | -2.023 a | 0.043 | 叶酸〔M(P25,P75),nmol/L〕 | 15.50(9.83,20.90) | 15.20(9.40,31.40) | -0.847a | 0.397 |
总蛋白(![]() | 64.34±7.23 | 62.40±5.99 | 2.232 | 0.026 | 25(OH)D(![]() | 22.97±6.22 | 19.88±7.22 | 3.765 | <0.001 |
白蛋白(![]() | 36.45±4.77 | 33.80±4.61 | 4.466 | <0.001 | 雌二醇(![]() | 116.65±56.51 | 132.96±49.92 | -2.369 | 0.018 |
总胆固醇(![]() | 4.16±1.11 | 3.96±1.00 | 1.456 | 0.146 | 睾酮(![]() | 7.20±7.33 | 9.31±7.68 | -2.250 | 0.025 |
三酰甘油(![]() | 1.45±0.91 | 1.38±1.00 | 0.561 | 0.575 | Hcy(![]() | 18.51±9.37 | 19.14±7.19 | -0.571 | 0.568 |
HDL(![]() | 1.06±0.34 | 1.00±0.26 | 1.721 | 0.087 | FINS(![]() | 8.22±7.73 | 6.92±5.41 | 1.455 | 0.147 |
LDL(![]() | 2.50±0.85 | 2.40±0.91 | 0.875 | 0.382 | APTT(![]() | 36.9±4.7 | 38.1±5.4 | -1.873 | 0.062 |
血钠(![]() | 139.05±3.41 | 139.09±3.74 | -0.082 | 0.934 | PT〔M(P25,P75),s〕 | 12.90(12.3,13.5) | 13.10(12.7,13.8) | -2.538a | 0.011 |
血钾〔M(P25,P75),mmol/L〕 | 3.90(3.70,4.20) | 4.00(3.70,4.40) | -1.840a | 0.066 | TT〔M(P25,P75),s〕 | 18.50(17.7,19.2) | 18.20(17.6,19.4) | -0.538a | 0.591 |
血氯(![]() | 107.13±4.56 | 106.89±3.76 | 0.437 | 0.662 | D-二聚体〔M(P25,P75),mg/L〕 | 1.44(0.97,2.39) | 1.55(1.30,2.51) | -2.541a | 0.011 |
血钙(![]() | 2.18±0.17 | 2.19±0.15 | -0.646 | 0.519 | TNF-α〔M(P25,P75),ng/L〕 | 6.32(4.74,10.65) | 7.03(5.14,10.19) | -1.092a | 0.275 |
肌酐(![]() | 88.91±47.59 | 81.01±32.04 | 1.437 | 0.152 | 白介素10〔M(P25,P75),ng/L〕 | 4.75(3.70,5.75) | 4.55(3.47,5.71) | -0.159a | 0.873 |
HbA1c〔M(P25,P75),%〕 | 6.2(5.7,6.9) | 6.1(5.7,6.6) | -0.701a | 0.483 | 白介素8〔M(P25,P75),ng/L〕 | 28.92(13.68,100.10) | 25.89(14.80,81.57) | -0.088a | 0.930 |
尿素氮(![]() | 7.39±3.70 | 11.07±19.11 | -1.801 | 0.075 | 白介素6〔M(P25,P75),ng/L〕 | 15.39(7.11,24.90) | 16.38(8.76,32.94) | -2.007a | 0.045 |
尿酸(![]() | 374.50±122.74 | 380.33±126.03 | -0.374 | 0.709 | 白介素1β〔M(P25,P75),ng/L〕 | 5.09(3.76,6.24) | 5.66(4.60,8.10) | -3.260a | 0.001 |
TSH〔M(P25,P75),mU/L〕 | 2.63(1.45,4.49) | 2.53(1.40,4.58) | -0.030a | 0.976 |
Table 2 Comparison of biomarkers between the two groups
项目 | 非COPD组(n=216) | COPD组(n=89) | t(Z)值 | P值 | 项目 | 非COPD组(n=216) | COPD组(n=89) | t(Z)值 | P值 |
---|---|---|---|---|---|---|---|---|---|
白细胞计数(![]() | 6.7±2.9 | 6.7±1.9 | 0.027 | 0.979 | T3(![]() | 1.11±0.43 | 1.07±0.30 | 1.011 | 0.313 |
血红蛋白(![]() | 132±23 | 138±28 | -1.649 | 0.101 | T4(![]() | 79.01±21.30 | 74.10±11.71 | 2.575 | 0.011 |
血小板计数(![]() | 208.3±77.4 | 185.4±70.3 | 2.410 | 0.017 | 铁蛋白(![]() | 326.30±285.71 | 298.38±400.38 | 0.686 | 0.493 |
NEUT〔M(P25,P75),×109/L〕 | 3.87(2.83,4.90) | 4.26(3.48,5.30) | -1.861a | 0.063 | 维生素B12〔M(P25,P75),pmol/L〕 | 352.50(230.25,499.14) | 398.00(254.50,580.00) | -1.478a | 0.139 |
C反应蛋白〔M(P25,P75),mg/L〕 | 3.47(0.77,21.03) | 7.34(2.51,21.82) | -2.023 a | 0.043 | 叶酸〔M(P25,P75),nmol/L〕 | 15.50(9.83,20.90) | 15.20(9.40,31.40) | -0.847a | 0.397 |
总蛋白(![]() | 64.34±7.23 | 62.40±5.99 | 2.232 | 0.026 | 25(OH)D(![]() | 22.97±6.22 | 19.88±7.22 | 3.765 | <0.001 |
白蛋白(![]() | 36.45±4.77 | 33.80±4.61 | 4.466 | <0.001 | 雌二醇(![]() | 116.65±56.51 | 132.96±49.92 | -2.369 | 0.018 |
总胆固醇(![]() | 4.16±1.11 | 3.96±1.00 | 1.456 | 0.146 | 睾酮(![]() | 7.20±7.33 | 9.31±7.68 | -2.250 | 0.025 |
三酰甘油(![]() | 1.45±0.91 | 1.38±1.00 | 0.561 | 0.575 | Hcy(![]() | 18.51±9.37 | 19.14±7.19 | -0.571 | 0.568 |
HDL(![]() | 1.06±0.34 | 1.00±0.26 | 1.721 | 0.087 | FINS(![]() | 8.22±7.73 | 6.92±5.41 | 1.455 | 0.147 |
LDL(![]() | 2.50±0.85 | 2.40±0.91 | 0.875 | 0.382 | APTT(![]() | 36.9±4.7 | 38.1±5.4 | -1.873 | 0.062 |
血钠(![]() | 139.05±3.41 | 139.09±3.74 | -0.082 | 0.934 | PT〔M(P25,P75),s〕 | 12.90(12.3,13.5) | 13.10(12.7,13.8) | -2.538a | 0.011 |
血钾〔M(P25,P75),mmol/L〕 | 3.90(3.70,4.20) | 4.00(3.70,4.40) | -1.840a | 0.066 | TT〔M(P25,P75),s〕 | 18.50(17.7,19.2) | 18.20(17.6,19.4) | -0.538a | 0.591 |
血氯(![]() | 107.13±4.56 | 106.89±3.76 | 0.437 | 0.662 | D-二聚体〔M(P25,P75),mg/L〕 | 1.44(0.97,2.39) | 1.55(1.30,2.51) | -2.541a | 0.011 |
血钙(![]() | 2.18±0.17 | 2.19±0.15 | -0.646 | 0.519 | TNF-α〔M(P25,P75),ng/L〕 | 6.32(4.74,10.65) | 7.03(5.14,10.19) | -1.092a | 0.275 |
肌酐(![]() | 88.91±47.59 | 81.01±32.04 | 1.437 | 0.152 | 白介素10〔M(P25,P75),ng/L〕 | 4.75(3.70,5.75) | 4.55(3.47,5.71) | -0.159a | 0.873 |
HbA1c〔M(P25,P75),%〕 | 6.2(5.7,6.9) | 6.1(5.7,6.6) | -0.701a | 0.483 | 白介素8〔M(P25,P75),ng/L〕 | 28.92(13.68,100.10) | 25.89(14.80,81.57) | -0.088a | 0.930 |
尿素氮(![]() | 7.39±3.70 | 11.07±19.11 | -1.801 | 0.075 | 白介素6〔M(P25,P75),ng/L〕 | 15.39(7.11,24.90) | 16.38(8.76,32.94) | -2.007a | 0.045 |
尿酸(![]() | 374.50±122.74 | 380.33±126.03 | -0.374 | 0.709 | 白介素1β〔M(P25,P75),ng/L〕 | 5.09(3.76,6.24) | 5.66(4.60,8.10) | -3.260a | 0.001 |
TSH〔M(P25,P75),mU/L〕 | 2.63(1.45,4.49) | 2.53(1.40,4.58) | -0.030a | 0.976 |
自变量 | 赋值 | 自变量 | 赋值 |
---|---|---|---|
年龄 | 60~74岁=1,75~84岁=2,≥85岁=3 | 血小板计数 | 实测值 |
性别 | 男=1,女=2 | C反应蛋白 | 实测值 |
当前吸烟 | 否=0,是=1 | 总蛋白 | 实测值 |
营养状况 | 营养良好=0,潜在营养不良=1,营养不良=2 | 白蛋白 | 实测值 |
认知功能 | 正常=0,轻度障碍=1,中度障碍=2,重度障碍=3 | T4 | 实测值 |
抑郁状态 | 否=0,是=1 | 25(OH)D | 实测值 |
焦虑状态 | 否=0,是=1 | 雌二醇 | 实测值 |
失能 | 否=0,是=1 | 睾酮 | 实测值 |
睡眠状况 | 良好=0,潜在失眠=1,失眠=2 | PT | 实测值 |
衰弱程度 | 无衰弱=0,衰弱前期=1,衰弱=2 | D-二聚体 | 实测值 |
多重用药 | 否=0,是=1 | 白介素6 | 实测值 |
用药种数 | 实测值 | 白介素1β | 实测值 |
Table 3 Independent variable assessments of binary Logistic regression analysis of influencing factors of COPD in elderly inpatients
自变量 | 赋值 | 自变量 | 赋值 |
---|---|---|---|
年龄 | 60~74岁=1,75~84岁=2,≥85岁=3 | 血小板计数 | 实测值 |
性别 | 男=1,女=2 | C反应蛋白 | 实测值 |
当前吸烟 | 否=0,是=1 | 总蛋白 | 实测值 |
营养状况 | 营养良好=0,潜在营养不良=1,营养不良=2 | 白蛋白 | 实测值 |
认知功能 | 正常=0,轻度障碍=1,中度障碍=2,重度障碍=3 | T4 | 实测值 |
抑郁状态 | 否=0,是=1 | 25(OH)D | 实测值 |
焦虑状态 | 否=0,是=1 | 雌二醇 | 实测值 |
失能 | 否=0,是=1 | 睾酮 | 实测值 |
睡眠状况 | 良好=0,潜在失眠=1,失眠=2 | PT | 实测值 |
衰弱程度 | 无衰弱=0,衰弱前期=1,衰弱=2 | D-二聚体 | 实测值 |
多重用药 | 否=0,是=1 | 白介素6 | 实测值 |
用药种数 | 实测值 | 白介素1β | 实测值 |
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) | |
---|---|---|---|---|---|---|
当前吸烟 | 0.855 | 0.410 | 4.354 | 0.037 | 2.351(1.053,5.249) | |
营养状况 | - | - | 7.694 | 0.021 | - | |
潜在营养不良 | 0.888 | 0.396 | 5.031 | 0.025 | 2.429(1.118,5.276) | |
营养不良 | 1.370 | 0.544 | 6.338 | 0.012 | 3.936(1.355,11.439) | |
失眠 | 0.949 | 0.438 | 4.687 | 0.030 | 2.584(1.094,6.102) | |
C反应蛋白 | -0.012 | 0.006 | 4.331 | 0.037 | 0.988(0.978,0.999) | |
25(OH)D | -0.074 | 0.028 | 6.996 | 0.008 | 0.929(0.880,0.981) | |
白介素1β | 0.025 | 0.011 | 5.165 | 0.023 | 1.025(1.003,1.047) |
Table 4 Binary Logistic regression analysis of influencing factors of COPD in elderly inpatients
变量 | β | SE | Wald χ2值 | P值 | OR(95%CI) | |
---|---|---|---|---|---|---|
当前吸烟 | 0.855 | 0.410 | 4.354 | 0.037 | 2.351(1.053,5.249) | |
营养状况 | - | - | 7.694 | 0.021 | - | |
潜在营养不良 | 0.888 | 0.396 | 5.031 | 0.025 | 2.429(1.118,5.276) | |
营养不良 | 1.370 | 0.544 | 6.338 | 0.012 | 3.936(1.355,11.439) | |
失眠 | 0.949 | 0.438 | 4.687 | 0.030 | 2.584(1.094,6.102) | |
C反应蛋白 | -0.012 | 0.006 | 4.331 | 0.037 | 0.988(0.978,0.999) | |
25(OH)D | -0.074 | 0.028 | 6.996 | 0.008 | 0.929(0.880,0.981) | |
白介素1β | 0.025 | 0.011 | 5.165 | 0.023 | 1.025(1.003,1.047) |
[1] | 中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志,2021,44(3):170-205. |
[2] | WANG C,XU J,YANG L,et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):a national cross-sectional study[J]. Lancet,2018,391(10131):1706-1717. |
[3] | SEHGAL I S,DHOORIA S,AGARWAL R. Chronic obstructive pulmonary disease and malnutrition in developing countries[J]. Curr Opin Pulm Med,2017,23(2):139-148. |
[4] | ARSLAN M,SOYLU M,KANER G,et al. Evaluation of malnutrition detected with the Nutritional Risk Screening 2002(NRS-2002)and the quality of life in hospitalized patients with chronic obstructive pulmonary disease[J]. Hippokratia,2016,20(2):147-152. |
[5] | 胡丽,赵旭,黄小明. 老年慢性阻塞性肺疾病患者营养状况及其与少肌症的相关性[J]. 国际老年医学杂志,2021,42(1):31-35. DOI:10.3969/j.issn.1674-7593.2021.01.009. |
[6] | TESTA G,CACCIATORE F,BIANCO A,et al. Chronic obstructive pulmonary disease and long-term mortality in elderly subjects with chronic heart failure[J]. Aging Clin Exp Res,2017,29(6):1157-1164. DOI:10.1007/s40520-016-0720-5. |
[7] | ALLARD J P,KELLER H,JEEJEEBHOY K N,et al. Malnutrition at hospital admission-contributors and effect on length of stay:a prospective cohort study from the Canadian Malnutrition Task Force[J]. JPEN J Parenter Enteral Nutr,2016,40(4):487-497. |
[8] | SHARMA Y,MILLER M,KAAMBWA B,et al. Malnutrition and its association with readmission and death within 7 days and 8-180 days postdischarge in older patients:a prospective observational study[J]. BMJ Open,2017,7(11):e018443. |
[9] | SCODITTI E,MASSARO M,GARBARINO S,et al. Role of diet in chronic obstructive pulmonary disease prevention and treatment[J]. Nutrients,2019,11(6):1357. DOI:10.3390/nu11061357. |
[10] | GOLOGANU D,IONITA D,GARTONEA T,et al. Body composition in patients with chronic obstructive pulmonary disease[J]. Maedica(Bucur),2014,9(1):25-32. |
[11] | 卢孔渺,黄曼. 重症患者的肠内营养喂养方式:间断喂养,还是持续喂养[J]. 中华急诊医学杂志,2020,29(1):137-140. DOI:10.3760/cma.j.issn.1671-0282.2020.01.023. |
[12] | SULO S,FELDSTEIN J,PARTRIDGE J,et al. Budget impact of a comprehensive nutrition-focused quality improvement program for malnourished hospitalized patients[J]. Am Health Drug Benefits,2017,10(5):262-270. |
[13] | PHILIPSON T J,SNIDER J T,LAKDAWALLA D N,et al. Impact of oral nutritional supplementation on hospital outcomes[J]. Am J Manag Care,2013,19(2):121-128. |
[14] | JANSSENS W,BOUILLON R,CLAES B,et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene[J]. Thorax,2010,65(3):215-220. DOI:10.1136/thx.2009.120659. |
[15] | ZHU M,WANG T,WANG C,et al. The association between vitamin D and COPD risk,severity,and exacerbation:an updated systematic review and meta-analysis[J]. Int J Chron Obstruct Pulmon Dis,2016,11:2597-2607. |
[16] | KENTSON M,LEANDERSON P,JACOBSON P,et al. The influence of disease severity and lifestyle factors on the peak annual 25(OH)D value of COPD patients[J]. Int J Chron Obstruct Pulmon Dis,2018,13:1389-1398. |
[17] | LOKESH K S,CHAYA S K,JAYARAJ B S,et al. Vitamin D deficiency is associated with chronic obstructive pulmonary disease and exacerbation of COPD[J]. Clin Respir J,2021,15(4):389-399. DOI:10.1111/crj.13310. |
[18] | HERR C,GREULICH T,KOCZULLA R A,et al. The role of vitamin D in pulmonary disease:COPD,asthma,infection,and cancer[J]. Respir Res,2011,12(1):31. |
[19] | ILYAS M,AGUSSALIM A,MEGAWATI M,et al. Relationship between vitamin D level and serum TNF-α concentration on the severity of chronic obstructive pulmonary disease[J]. Open Access Maced J Med Sci,2019,7(14):2298-2304. |
[20] | KHAN D M,ULLAH A,RANDHAWA F A,et al. Role of vitamin D in reducing number of acute exacerbations in chronic obstructive pulmonary disease(COPD)patients[J]. Pak J Med Sci,2017,33(3):610-614. DOI:10.12669/pjms.333.12397. |
[21] | ZENDEDEL A,GHOLAMI M,ANBARI K,et al. Effects of vitamin D intake on FEV1 and COPD exacerbation:a randomized clinical trial study[J]. Glob J Health Sci,2015,7(4):243-248. DOI:10.5539/gjhs.v7n4p243. |
[22] | AFZAL S,LANGE P,BOJESEN S E,et al. Plasma 25-hydroxyvitamin D,lung function and risk of chronic obstructive pulmonary disease[J]. Thorax,2014,69(1):24-31. |
[23] | SUNDAR I K,HWANG J W,WU S,et al. Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation[J]. Biochem Biophys Res Commun,2011,406(1):127-133. |
[24] | JOLLIFFE D A,GREENBERG L,HOOPER R L,et al. Vitamin D to prevent exacerbations of COPD:systematic review and meta-analysis of individual participant data from randomised controlled trials[J]. Thorax,2019,74(4):337-345. |
[25] | WEBER A,WASILIEW P,KRACHT M. Interleukin-1(IL-1)pathway[J]. Sci Signal,2010,3(105):cm1. |
[26] | OZRETIC P,DA SILVA FILHO M I,CATALANO C,et al. Association of NLRP1 coding polymorphism with lung function and serum IL-1β concentration in patients diagnosed with chronic obstructive pulmonary disease(COPD)[J]. Genes(Basel),2019,10(10):783. DOI:10.3390/genes10100783. |
[27] | ZOU Y,CHEN X,LIU J,et al. Serum IL-1β and IL-17 levels in patients with COPD:associations with clinical parameters[J]. Int J Chron Obstruct Pulmon Dis,2017,12:1247-1254. DOI:10.2147/COPD.S131877. |
[28] | KHAN Y M,KIRKHAM P,BARNES P J,et al. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells[J]. PLoS One,2014,9(4):e95051. |
[29] | PAUWELS N S,BRACKE K R,DUPONT L L,et al. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD[J]. Eur Respir J,2011,38(5):1019-1028. DOI:10.1183/09031936.00158110. |
[30] | KITAMURA H,CAMBIER S,SOMANATH S,et al. Mouse and human lung fibroblasts regulate dendritic cell trafficking,airway inflammation,and fibrosis through integrin αvβ8-mediated activation of TGF-β[J]. J Clin Invest,2011,121(7):2863-2875. DOI:10.1172/JCI45589. |
[31] | 吴雨珊,金寿德,强丽霞,等. IL-1β、IL-6及TNF-α在慢性阻塞性肺疾病中的作用及研究进展[J]. 国际呼吸杂志,2021,41(4):298-303. DOI:10.3760/cma.j.cn131368-20200522-00428. |
[1] | FENG Xiaoyu, LI Wanling, LYU Siman, NI Cuiping, WANG Haocheng, LIU Yu. International Research Status and Hot Spot Analysis of InterRAI HC Based on Bibliometrics [J]. Chinese General Practice, 2023, 26(34): 4351-4358. |
[2] | GU Hanxin, LIU Yang, LIU Yuanli. Falls Prevention Intervention for Community-dwelling Older Adults from the Perspective of Policy Tools: an International Comparative Study [J]. Chinese General Practice, 2023, 26(34): 4231-4238. |
[3] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[4] | YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172. |
[5] | XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109. |
[6] | ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006. |
[7] | JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079. |
[8] | CHEN Xi, ZHANG Juan, LI Lin, ZHANG Jiaqi, WU Yaoli, GUO Hui, WANG Chaoqun. Association between Physical Activity and Risk of All-cause Mortality in Middle-aged and Elderly People in China: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(31): 3890-3895. |
[9] | ZHANG Peng, GAO Ying, YANG Hongxi, WAN Chunxiao. Association between Serum Uric Acid Level and the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China [J]. Chinese General Practice, 2023, 26(31): 3884-3889. |
[10] | DUAN Yanqin, PENG Ying, LIU Shenglan, LIU Haijiao, YANG Huiqiong, HU Haiqing. Prevalence and Associated Factors of Potentially Inappropriate Medication among Elderly Outpatients [J]. Chinese General Practice, 2023, 26(31): 3902-3907. |
[11] | ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784. |
[12] | PAN Yaojia, WANG Weiqiang, YI Weizhuo, GAO Bing, FU Fanglin, HAN Zheng, SUN Meng, DONG Yaqin, GU Huaicong. Relationship between Triglyceride-glucose Index and Risk of Cardiovascular Diseases in Middle-aged Obese Residents of Different Genders [J]. Chinese General Practice, 2023, 26(29): 3628-3635. |
[13] | ZHOU Sijing, LUO Bangan, CAO Hui, ZHANG Xi, WANG Dongxin. Epidemiological Characteristics of Dementia and Its Correlation with Multimorbidity among Residents Aged 65 and Above [J]. Chinese General Practice, 2023, 26(29): 3616-3621. |
[14] | WANG Xiaoran, ZHANG Dan. Influence of Multimorbidity on Anxiety Symptoms among Chinese Elderly People: a Propensity Score-matched Study [J]. Chinese General Practice, 2023, 26(29): 3622-3627. |
[15] | ZHOU Xiaoqi, LIU Xinhui, ZHANG Wei, LI Changfeng, YAN Yaqiong. Association of Alanine Transaminase and Aspartate Aminotransferase/Alanine Transaminase Ratio with Type 2 Diabetes and Metabolic Syndrome in the Elderly [J]. Chinese General Practice, 2023, 26(29): 3645-3649. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||